Whole genome sequencing to help you improve your health and longevity. $999. U.S. price.
A simple screening test to help you understand your risk for hereditary breast and ovarian cancer.
Screening test of 26 genes, including BRCA1 and BRCA2, for increased risk of developing breast, ovarian, and other inherited cancers.
Maternal blood-based non-invasive screening that predicts the presence of Down Syndrome (T21), Edwards Syndrome (T18), and Patau Syndrome (T13).
Saliva-based screening of prospective or currently pregnant parents to see if they carry inherited and rare conditions such as cystic fibrosis.
Comprehensive genetic screening of newborns for early childhood diseases.
Industry-leading genetic tests, whole genome sequencing, and interpretation for your patients.
Customized, fully integrated, research-only whole genome sequencing services.
Industry-leading genetic tests and genome sequencing solutions.
A screening test that identifies mutations in 26 genes, including BRCA1 and BRCA2, which are associated with increased risk for developing breast, ovarian, and other inherited cancers.
* Close blood relatives: first-degree (parents, children, siblings), second-degree (grandparents, aunts/uncles, nieces/nephews, half siblings), and third degree (first cousins, great aunts/ uncles/grandparents)
If you are not at high risk but are still interested in a BRCA1 and BRCA2 screening test, please check out myBRCA.
A BRCA mutation can increase the lifetime risk of breast cancer in women from 12% to up to 80% by age 80.3
general population risk
with BRCA mutation
A BRCA mutation can increase the lifetime risk of ovarian cancer in women from 1.3% to up to 40% by age 80.3
A report with your personal results and considerations for you to discuss with your doctor
A complimentary call with one of our genetic counselors to review your results upon request (currently applies to US only)
Insights to help you and your doctor determine the most appropriate preventive, clinical, and lifestyle considerations based on your hereditary risk.
Comprehensive analysis of 26 genes associated with hereditary breast and ovarian cancer.
These genes may also be associated with increased risk for:
Talk to your doctor about ordering the myBRCA HiRisk test for you.
Your sample is collected per your physician's instructions
Once we receive your sample, we process it at our CLIA lab and provide results within 4-5 weeks
We let you and your doctor know that your results are ready on our secure site
Find out more about possible outcomes and other technical information.
Let us know and our team will get in touch with you.